OhioHealth Marion General Hospital, First in the United States to use the FLEX® Scoring Catheter to Treat Complex Dialysis Interventions

TOLEDO, Ohio, Sept. 28, 2017 /PRNewswire/ – VentureMed Group®, Inc. (“VMG” or the “Company”), a medical device company developing and commercializing next-generation endovascular products to treat patients with peripheral artery disease (PAD) and stenosed Arteriovenous fistulaes (AVF) and Arteriovenous grafts (AVG), today announced the treatment of the first patient in the U.S. using FLEX® Scoring Catheter in patients with end-stage renal disease.

Patients who are not candidates for renal transplants or when a donor cannot be secured, become dependent on hemodialysis for the remainder of their life. This situation results in the long-term need for dialysis access. The preservation of patent, well-functioning dialysis fistulas, is one of the most difficult clinical problems in the long-term treatment of patients undergoing dialysis. As many as 25 percent of hospital admissions in the dialysis population have been attributed to vascular access complications, including fistulae malfunction, stenosis and thrombosis. Less than 15 percent of dialysis fistulas remain patent and can function without problems during the entire period of a patient’s dependence on hemodialysis. 

OhioHealth Marion General Hospital has announced Dr. Jose Vale was the first physician in the United States to offer VentureMed‘s FLEX Scoring Catheter® to its patients with end stage renal disease. “Vascular access is a hemodialysis patient’s life line. AV fistulas and AV grafts make hemodialysis treatments possible,” Dr. Vale said after successfully treating the first ever dialysis patient in the United States using the FLEX Scoring Catheter. These access sites often become occluded, making it difficult for patients, like the ones seen by Dr. Vale at Marion General Hospital, to receive these life-saving procedures.  “FLEX allowed me to successfully recanalize the patient’s occlusion and there have been no reports of incomplete or suboptimal dialysis treatments from…

Read the full article at the Original Source..

Back to Top